PDB Short entry for 4D5M HEADER HORMONE 05-NOV-14 4D5M TITLE GONADOTROPIN-RELEASING HORMONE AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIPTORELIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: TRIPTORELIN IS A MEDICINE AVAILABLE IN A NUMBER OF COMPND 6 COUNTRIES WORLDWIDE. IT IS AN ANALOGOUS OF THE GONADOTROPIN-RELEASING COMPND 7 HORMONE. 5-OXO-D-PROLYL-L-HISTIDYL-L-TRYPTOPHANYL-L-SERYL-L-TYROSYL- COMPND 8 D-TRYPTOPHANYL-L-LEUCYL-L-ARGINYL-L-PROLYL-L-GLYCINAMIDE. SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 OTHER_DETAILS: TRIPTORELIN IS A MEDICINE AVAILABLE IN A NUMBER OF SOURCE 6 COUNTRIES WORLDWIDE. KEYWDS HORMONE, GNRH, LHRH, D-TRP, DECAPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR P.LEGRAND,M.-H.LE DU,C.VALERY,S.DEVILLE-FOILLARD,M.PATERNOSTRE, AUTHOR 2 F.ARTZNER REVDAT 2 11-MAR-20 4D5M 1 SEQRES LINK REVDAT 1 12-AUG-15 4D5M 0 JRNL AUTH C.VALERY,S.DEVILLE-FOILLARD,C.LEFEBVRE,N.TABERNER,P.LEGRAND, JRNL AUTH 2 F.MENEAU,C.MERIADEC,C.DELVAUX,T.BIZIEN,E.KASOTAKIS, JRNL AUTH 3 C.LOPEZ-IGLESIAS,A.GALL,S.BRESSANELLI,M.-H.LE DU, JRNL AUTH 4 M.PATERNOSTRE,F.ARTZNER JRNL TITL ATOMIC VIEW OF THE HISTIDINE ENVIRONMENT STABILIZING HIGHER- JRNL TITL 2 PH CONFORMATIONS OF PH-DEPENDENT PROTEINS. JRNL REF NAT.COMMUN. V. 6 7771 2015 JRNL REFN ESSN 2041-1723 JRNL PMID 26190377 JRNL DOI 10.1038/NCOMMS8771 REMARK 2 REMARK 2 RESOLUTION. 0.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 24802 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.080 REMARK 3 R VALUE (WORKING SET) : 0.080 REMARK 3 FREE R VALUE : 0.087 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1306 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 0.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 0.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1658 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.1740 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.1620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 380 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 1.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.011 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.011 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.006 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.195 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.991 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.996 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 472 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 379 ; 0.009 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 637 ; 1.647 ; 1.809 REMARK 3 BOND ANGLES OTHERS (DEGREES): 826 ; 0.875 ; 2.978 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 38 ; 7.556 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 22 ;41.492 ;18.182 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 42 ;10.810 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;15.600 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 45 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 532 ; 0.018 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 156 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 184 ; 0.410 ; 0.124 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 182 ; 0.404 ; 0.125 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 208 ; 0.500 ; 0.188 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 209 ; 0.499 ; 0.187 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 288 ; 0.509 ; 0.161 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 289 ; 0.508 ; 0.161 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 430 ; 0.697 ; 0.238 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 685 ; 1.227 ; 1.634 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 658 ; 1.092 ; 1.472 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 851 ; 5.515 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 6 ; 5.404 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 868 ; 2.528 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4D5M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-NOV-14. REMARK 100 THE DEPOSITION ID IS D_1290062121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.78471 REMARK 200 MONOCHROMATOR : CHANNEL-CUT MONOCHROMATOR SI 111 REMARK 200 OPTICS : KB MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24802 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.850 REMARK 200 RESOLUTION RANGE LOW (A) : 41.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 26.60 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.20000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT METHODS REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 14.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM POTASSIUM PHOSPHATE BUFFER, PH REMARK 280 6.2 MIXED WITH 80 MG/ML TRIPTORELIN IN WATER. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.45000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 13.73500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.45000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 13.73500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 O1 PO4 A1011 LIES ON A SPECIAL POSITION. REMARK 375 O1 PO4 B1011 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 2 132.10 177.88 REMARK 500 HIS B 2 132.84 -174.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 C 1011 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 1011 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1011 REMARK 999 REMARK 999 SEQUENCE REMARK 999 TRIPTORELIN IS RELATED TO GONADORELIN WITH THE G6W. DBREF 4D5M A 1 11 PDB 4D5M 4D5M 1 11 DBREF 4D5M B 1 11 PDB 4D5M 4D5M 1 11 DBREF 4D5M C 1 11 PDB 4D5M 4D5M 1 11 DBREF 4D5M D 1 11 PDB 4D5M 4D5M 1 11 SEQRES 1 A 11 PCA HIS TRP SER TYR DTR LEU ARG PRO GLY NH2 SEQRES 1 B 11 PCA HIS TRP SER TYR DTR LEU ARG PRO GLY NH2 SEQRES 1 C 11 PCA HIS TRP SER TYR DTR LEU ARG PRO GLY NH2 SEQRES 1 D 11 PCA HIS TRP SER TYR DTR LEU ARG PRO GLY NH2 MODRES 4D5M PCA A 1 GLU PYROGLUTAMIC ACID MODRES 4D5M PCA B 1 GLU PYROGLUTAMIC ACID MODRES 4D5M PCA C 1 GLU PYROGLUTAMIC ACID MODRES 4D5M PCA D 1 GLU PYROGLUTAMIC ACID HET PCA A 1 28 HET DTR A 6 24 HET NH2 A 11 6 HET PCA B 1 28 HET DTR B 6 24 HET NH2 B 11 6 HET PCA C 1 14 HET DTR C 6 24 HET NH2 C 11 3 HET PCA D 1 14 HET DTR D 6 24 HET NH2 D 11 3 HET PO4 A1011 5 HET PO4 B1011 5 HET PO4 C1011 5 HETNAM PCA PYROGLUTAMIC ACID HETNAM DTR D-TRYPTOPHAN HETNAM NH2 AMINO GROUP HETNAM PO4 PHOSPHATE ION FORMUL 1 PCA 4(C5 H7 N O3) FORMUL 1 DTR 4(C11 H12 N2 O2) FORMUL 1 NH2 4(H2 N) FORMUL 5 PO4 3(O4 P 3-) FORMUL 8 HOH *45(H2 O) HELIX 1 1 HIS A 2 DTR A 6 5 5 HELIX 2 2 HIS B 2 DTR B 6 5 5 HELIX 3 3 HIS C 2 DTR C 6 5 5 HELIX 4 4 HIS D 2 DTR D 6 5 5 LINK C APCA A 1 N HIS A 2 1555 1555 1.41 LINK C BPCA A 1 N HIS A 2 1555 1555 1.38 LINK C ATYR A 5 N DTR A 6 1555 1555 1.34 LINK C BTYR A 5 N DTR A 6 1555 1555 1.34 LINK C DTR A 6 N LEU A 7 1555 1555 1.34 LINK C AGLY A 10 N ANH2 A 11 1555 1555 1.31 LINK C BGLY A 10 N BNH2 A 11 1555 1555 1.28 LINK C BPCA B 1 N HIS B 2 1555 1555 1.45 LINK C APCA B 1 N HIS B 2 1555 1555 1.27 LINK C ATYR B 5 N DTR B 6 1555 1555 1.33 LINK C BTYR B 5 N DTR B 6 1555 1555 1.34 LINK C DTR B 6 N LEU B 7 1555 1555 1.33 LINK C BGLY B 10 N BNH2 B 11 1555 1555 1.31 LINK C AGLY B 10 N ANH2 B 11 1555 1555 1.30 LINK C PCA C 1 N HIS C 2 1555 1555 1.35 LINK C TYR C 5 N DTR C 6 1555 1555 1.33 LINK C DTR C 6 N LEU C 7 1555 1555 1.33 LINK C GLY C 10 N NH2 C 11 1555 1555 1.32 LINK C PCA D 1 N HIS D 2 1555 1555 1.34 LINK C TYR D 5 N DTR D 6 1555 1555 1.33 LINK C DTR D 6 N LEU D 7 1555 1555 1.34 LINK C GLY D 10 N NH2 D 11 1555 1555 1.34 SITE 1 AC5 11 PCA C 1 HIS C 2 ARG C 8 HOH C2001 SITE 2 AC5 11 HOH C2003 HOH C2015 PCA D 1 HIS D 2 SITE 3 AC5 11 ARG D 8 GLY D 10 HOH D2001 SITE 1 AC6 6 HIS A 2 PCA B 1 ARG B 8 GLY B 10 SITE 2 AC6 6 HOH B2001 HOH B2003 SITE 1 AC7 7 PCA A 1 ARG A 8 GLY A 10 HOH A2001 SITE 2 AC7 7 HOH A2003 HOH A2015 HIS B 2 CRYST1 84.900 27.470 13.150 90.00 98.83 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011779 0.000000 0.001830 0.00000 SCALE2 0.000000 0.036403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.076958 0.00000 MTRIX1 1 1.000000 0.009000 0.005000 -0.05770 1 MTRIX2 1 -0.009000 1.000000 -0.002000 -13.72572 1 MTRIX3 1 -0.005000 0.002000 1.000000 0.00171 1 MTRIX1 2 -1.000000 -0.004000 0.016000 17.07359 1 MTRIX2 2 -0.004000 1.000000 0.016000 -7.05721 1 MTRIX3 2 -0.016000 0.016000 -1.000000 25.86929 1 MTRIX1 3 -1.000000 -0.011000 -0.009000 17.52489 1 MTRIX2 3 -0.011000 1.000000 -0.008000 -20.43805 1 MTRIX3 3 0.009000 -0.008000 -1.000000 26.04363 1 HETATM 1 N APCA A 1 -2.087 16.449 8.725 0.54 1.72 N ANISOU 1 N APCA A 1 184 162 306 -23 5 25 N HETATM 2 N BPCA A 1 -1.742 16.554 9.771 0.46 2.22 N ANISOU 2 N BPCA A 1 382 163 296 -55 116 -122 N HETATM 3 CA APCA A 1 -2.856 17.649 8.521 0.54 1.47 C ANISOU 3 CA APCA A 1 60 156 342 -32 19 -55 C HETATM 4 CA BPCA A 1 -2.680 17.577 9.363 0.46 2.62 C ANISOU 4 CA BPCA A 1 222 236 534 -32 82 -161 C HETATM 5 CB APCA A 1 -3.724 17.773 9.831 0.54 1.85 C ANISOU 5 CB APCA A 1 144 187 371 -15 64 -38 C HETATM 6 CB BPCA A 1 -3.523 17.775 10.654 0.46 3.96 C ANISOU 6 CB BPCA A 1 359 381 763 -146 249 -264 C HETATM 7 CG APCA A 1 -2.948 16.928 10.842 0.54 2.60 C ANISOU 7 CG APCA A 1 370 294 321 -106 -4 -22 C HETATM 8 CG BPCA A 1 -2.614 17.285 11.780 0.46 4.23 C ANISOU 8 CG BPCA A 1 810 281 513 -140 328 -69 C HETATM 9 CD APCA A 1 -2.114 16.000 10.000 0.54 2.24 C ANISOU 9 CD APCA A 1 331 228 289 -28 -64 28 C HETATM 10 CD BPCA A 1 -1.664 16.350 11.101 0.46 3.67 C ANISOU 10 CD BPCA A 1 951 106 335 -63 155 -38 C HETATM 11 OE APCA A 1 -1.539 14.976 10.394 0.54 3.08 O ANISOU 11 OE APCA A 1 474 323 370 70 -39 87 O HETATM 12 OE BPCA A 1 -0.870 15.558 11.668 0.46 5.34 O ANISOU 12 OE BPCA A 1 1373 210 443 43 142 115 O HETATM 13 C APCA A 1 -2.022 18.919 8.337 0.54 1.59 C ANISOU 13 C APCA A 1 63 141 399 -16 40 -17 C HETATM 14 C BPCA A 1 -2.029 18.903 8.953 0.46 2.07 C ANISOU 14 C BPCA A 1 61 304 421 -23 26 -94 C HETATM 15 O APCA A 1 -2.574 19.945 8.056 0.54 1.61 O ANISOU 15 O APCA A 1 38 192 380 4 -42 -18 O HETATM 16 O BPCA A 1 -2.706 19.845 8.546 0.46 2.58 O ANISOU 16 O BPCA A 1 90 371 517 56 -49 -110 O HETATM 17 H APCA A 1 -1.572 16.033 7.958 0.54 1.70 H ANISOU 17 H APCA A 1 167 170 309 -30 -7 5 H HETATM 18 H BPCA A 1 -1.200 16.048 9.078 0.46 2.05 H ANISOU 18 H BPCA A 1 352 142 283 -15 88 -90 H HETATM 19 HA APCA A 1 -3.486 17.565 7.637 0.54 1.49 H ANISOU 19 HA APCA A 1 83 156 328 -26 20 -32 H HETATM 20 HA BPCA A 1 -3.286 17.246 8.521 0.46 2.54 H ANISOU 20 HA BPCA A 1 233 250 479 -47 108 -143 H HETATM 21 HB2APCA A 1 -4.738 17.402 9.690 0.54 1.85 H ANISOU 21 HB2APCA A 1 162 189 350 -31 41 -38 H HETATM 22 HB2BPCA A 1 -4.452 17.209 10.623 0.46 3.41 H ANISOU 22 HB2BPCA A 1 352 307 635 -118 212 -189 H HETATM 23 HB3APCA A 1 -3.840 18.810 10.135 0.54 1.78 H ANISOU 23 HB3APCA A 1 142 177 354 -36 34 -33 H HETATM 24 HB3BPCA A 1 -3.832 18.811 10.779 0.46 3.62 H ANISOU 24 HB3BPCA A 1 369 369 636 -124 210 -183 H HETATM 25 HG2APCA A 1 -2.327 17.527 11.505 0.54 2.25 H ANISOU 25 HG2APCA A 1 294 242 319 -55 0 -14 H HETATM 26 HG2BPCA A 1 -2.086 18.095 12.282 0.46 4.11 H ANISOU 26 HG2BPCA A 1 731 301 529 -92 278 -87 H HETATM 27 HG3APCA A 1 -3.600 16.359 11.503 0.54 2.30 H ANISOU 27 HG3APCA A 1 300 248 326 -51 -5 -19 H HETATM 28 HG3BPCA A 1 -3.159 16.769 12.568 0.46 3.68 H ANISOU 28 HG3BPCA A 1 696 254 444 -124 270 -101 H